92
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Combination of Gadolinium and Dysprosium Chelates as a Cellular Integrity Marker in MR Imaging

, , &
Pages 41-46 | Accepted 19 May 1994, Published online: 04 Jan 2010

References

  • Fossheim S., Saebo K. B., Grace D., Fahlvik A. K., Klaveness J. Susceptibility contrast agents. Studies of dysprosium and gadolinium in two-compartment in vitro models. Soc. Magn. Reson. Med., 12th Annual Meeting. New York 1993; 758, Abstract
  • Öksendal A., Hals P.-A. Biodistribution and toxicity of MR imaging contrast media. J. Magn. Reson. Imaging 1993; 3: 157
  • Saeed M., Wendland M. F., Tomei E., et al. Demarcation of myocardial ischaemia. Magnetic susceptibility effect of contrast medium in MR imaging. Radiology 1989; 173: 763
  • Sze G., Brant-Zawadzki M., Haughton V. M., et al. Multicenter study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991; 181: 693
  • Villringer A., Rosen B. R., Belliveau J. W., et al. Dynamic imaging with lanthanide chelates in normal brain. Contrast due to magnetic susceptibility effects. Magn. Reson. Med. 1988; 6: 164
  • Wikström M., Martinussen H. J., Ericsson A., Wikström G., Waldenström A., Hemmingsson A. Double-contrast enhanced MR imaging of myocardial infarction in the pig. Acta Radiol. 1993; 34: 64

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.